Cabergoline benefits and possible side effects

Cabergoline's applications in the endocrine field focus on reducing excessive prolactin levels. It inhibits prolactin secretion by selectively stimulating D2 dopamine receptors in the pituitary gland, thereby restoring normal hormone balance.

The clinical efficacy is reflected in many aspects. First of all, it can effectively improve amenorrhea, infertility, abnormal lactation and other problems caused by hyperprolactinemia (HPRL), and has a particularly obvious impact on female reproductive health. Secondly, in men, cabergoline can alleviate hypogonadism caused by elevated prolactin and improve hyposexuality and erectile dysfunction. In addition, for patients with pituitary prolactinoma, cabergoline can not only control hormone levels, but also reduce tumor size in most cases and reduce compression symptoms on the optic nerve and other surrounding tissues. This is a major advantage in its treatment.

Despite its outstanding clinical value, cabergoline may be associated with some side effects. The most common are gastrointestinal reactions, such as nausea, vomiting and stomach discomfort, which are usually more obvious in the initial stage. As the medication time is prolonged and the dosage is adjusted, most patients can gradually tolerate it. Some patients may experience dizziness, low blood pressure, or fatigue, especially when changing body positions. Therefore, it is recommended to take medication at night to reduce the effects.

A small number of patients may be at risk of heart valve fibrosis when used for a long time or in high doses. Although this risk is much lower than other ergot drugs, regular echocardiographic monitoring is still required to ensure safety. In addition, there may be mood swings, insomnia or mild depression, which are related to its effect on the central dopamine system.

Taken together, the efficacy of cabergoline is to significantly reduce prolactin levels, improve reproductive function and control tumor progression, and most of its side effects can be managed through rational medication and monitoring.

Reference materials:https://www.drugs.com/mtm/cabergoline.html